[Secondary prevention after stroke: healthy life style, oral anticoagulation].
For patients who suffered a TIA or a stroke the risk of a second event is high. The recurrence rate, however, can be significantly reduced by a number of prophylactic strategies. Methods for secondary stroke prevention include a healthy lifestyle, intensive body exercise, a low cholesterol diet, and the cessation of smoking. High levels of blood pressure, cholesterol and blood glucose should be rigorously controlled. In particular, blood pressure levels should remain below 135/85 mmHg including a physiological day/night profile. All patients at high risk for cardiac embolism should receive oral anticoagulants. As the risk for embolic events increases with age (especially in patients with atrial fibrillation), a rigid "age-cutoff" for anticoagulation is not justified.
Abteilung für Neurologie, Städt, Krankenhaus München-Harlaching.
H
H
Audebert
R L
RL
Haberl
D000284:Administration, Oral; D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications; D002545:Brain Ischemia / Q000209:etiology; D002343:Carotid Artery, Internal; D016893:Carotid Stenosis / Q000150:complications / Q000601:surgery; D002544:Cerebral Infarction / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects; D004617:Embolism / Q000150:complications / Q000517:prevention & control; D016894:Endarterectomy, Carotid; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D008019:Life Style; D008297:Male; D010644:Phenprocoumon / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D019821:Simvastatin / Q000627:therapeutic use; D016540:Smoking Cessation; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D003276:Contraceptives, Oral; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D019821:Simvastatin; D010644:Phenprocoumon